Lechemby and Agri-Hum Are the Best Antibodies

More than 6 million Americans live with Alzheimer’s, meaning it touches almost all our lives. That number could double by 2050, unless a cure is found. How far away are we? Andy speaks with Dr. Paul Aisen and Dr. Rudolph Tanzi about the genetic factors that contribute to Alzheimer’s, promising blood tests that can detect the disease long before symptoms begin, and a treatment that could be approved by the FDA as soon as July.

Keep up with Andy on Twitter and Post @ASlavitt.

Joining Lemonada Premium is a great way to support our show and get bonus content. Subscribe today at bit.ly/lemonadapremium. 

Support the show by checking out our sponsors!

• Click this link for a list of current sponsors and discount codes for this show and all Lemonada shows: https://lemonadamedia.com/sponsors/ 

Check out these resources from today’s episode: 

• Check out Rudolph’s book, where he explains the SHIELD plan:  https://www.penguinrandomhouse.com/books/539323/the-healing-self-by-deepak-chopra-md-and-rudolph-e-tanzi-phd/
• Find vaccines, masks, testing, treatments, and other resources in your community: https://www.covid.gov/
• Order Andy’s book, “Preventable: The Inside Story of How Leadership Failures, Politics, and Selfishness Doomed the U.S. Coronavirus Response”: https://us.macmillan.com/books/9781250770165 

Stay up to date with us on Twitter, Facebook, and Instagram at @LemonadaMedia. 

For additional resources, information, and a transcript of the episode, visit lemonadamedia.com/show/inthebubble.

See omnystudio.com/listener for privacy information.